Inpatient care for children with diabetes: are standards being met?

Julie Edge1, Frances M Ackland, Susan Payne

  • 1Department of Paediatric Endocrinology and Diabetes, Oxford Children's Hospital, Oxford OX3 9DU, UK. julie.edge@paediatrics.ox.ac.uk

Insights

Inpatient care for children with diabetes often falls short of standards, particularly in emergency departments. Improvements are needed in staffing, specialist nurse availability, and timely communication with diabetes teams.

Area of Science:

  • Pediatric Endocrinology
  • Healthcare Quality Improvement
  • Hospital Management

Background:

  • Parental dissatisfaction with pediatric inpatient diabetes care is common.
  • Hospital staff possess diminished familiarity with diabetes management due to decreased admissions and increased care complexity.

Purpose of the Study:

  • To evaluate current inpatient care practices for children with diabetes against established national standards.
  • To identify areas of non-compliance with the Department of Health Children's Diabetes Working Group guidelines.

Main Methods:

  • An audit was conducted across three regional networks in southern England.
  • Data were collected via questionnaires from 27 pediatric diabetes services.

Main Results:

  • Protocols for common diabetes emergencies were more available on wards than in emergency departments (EDs).
  • While children's nurses were present on all pediatric wards, their presence in EDs was inconsistent (33%).
  • Access to dietetic advice and timely communication with diabetes teams, especially out-of-hours, were significant challenges, with insulin errors reported by half of centers.

Conclusions:

  • The audit highlights variability in achieving inpatient care standards for pediatric diabetes.
  • Key areas requiring improvement include ED staffing, dietetic support, and out-of-hours diabetes team liaison.
  • Future work will focus on developing patient resources and refining care standards.
Abstract

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...